SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio Inc. today announced it has received a grant from the Gates ...

Bio Protocol enables researchers and patients to launch BioAgents - autonomous AI co-scientists that generate hypotheses, fund experiments and mo ...

OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership ...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, ...

A tick-targeting insecticide “derived from nature” that has in early stage lab testing shown to be a promising agent with ...

Bluebird Bio (BLUE) announced new and updated data from LYFGENIA gene therapy for patients with sickle cell disease who have a history of vaso-occlusive events. As of July 2024, 70 patients were ...

• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of ...

Entera Bio (ENTX) announced data selected for presentation at the American Society for Bone and Mineral Research 2025 Annual Meeting in Seattle, Washington, for its lead program EB613 which is in late ...